Recombinant hepatitis B vaccine (NCPC GeneTech Biotechnology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant hepatitis B vaccine (NCPC GeneTech Biotechnology)
Drug Alias NameGerVax
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1997/01/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNcpc Genetech Biotechnology Development
China Registration ClassN/A

Develop Information

Active CompaniesNcpc Genetech Biotechnology Development
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ07BC01
Related LinksN/A